Skip to Main Content

Paper Details

Clinical Response to Upfront Targeted Tyrosine Kinase Inhibitors among Patients with Myeloid/Lymphoid Neoplasms with Eosinophilia and Tyrosine Kinase Gene Fusion.
Clin Lymphoma Myeloma Leuk
4
2023
Author NameAffiliation
Bijal ShahH. Lee Moffitt Cancer Center and Research Institute
  • 1 - 1

Datasets

Release 1.2